18-month efficacy and safety update from JAVELIN Merkel 200 part A: A phase II study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy Meeting Abstract
| Authors: | D'Angelo, S. P.; Russell, J. S.; Bhatia, S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbé, C.; Lewis, K. D.; Linette, G. P.; Milella, M.; Hennessy, M.; Bajars, M.; Zwiener, I.; Nghiem, P. |
| Abstract Title: | 18-month efficacy and safety update from JAVELIN Merkel 200 part A: A phase II study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy |
| Meeting Title: | 2018 ASCO-SITC Clinical Immuno-Oncology Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2018 Jan 25-27 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-10 |
| Language: | English |
| ACCESSION: | WOS:000436177700183 |
| DOI: | 10.1200/JCO.2018.36.5_suppl.192 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 192 -- Source: Wos |
